Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quidel Corp (NASDAQ:QDEL)

22.17
Delayed Data
As of Sep 26
 -0.54 / -2.38%
Today’s Change
13.21
Today|||52-Week Range
23.94
+4.58%
Year-to-Date
Bruker-3M Company Expand FFPE Tissue Processing License
Sep 26 / Zacks.com - Paid Partner Content
ZELTIQ Aesthetics Hits a 52-Week High on Solid Prospects
Sep 15 / Zacks.com - Paid Partner Content
Hill-Rom Holdings Hits a 52-Week High on Solid Prospects
Sep 23 / Zacks.com - Paid Partner Content
Quidel (QDEL) Sees Hammer Chart Pattern: Time to Buy?
Sep 14 / Zacks.com - Paid Partner Content
Zimmer Biomet Introduces Vanguard Individualized Design
Sep 21 / Zacks.com - Paid Partner Content
Allscripts Clinches New Deal for Sunrise and CareInMotion
Sep 14 / Zacks.com - Paid Partner Content
Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Sep 20 / Zacks.com - Paid Partner Content
Cynosure Appoints Stephen J. Webber to CFO & Other Roles
Sep 14 / Zacks.com - Paid Partner Content
CR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB
Sep 20 / Zacks.com - Paid Partner Content
Medtronic IN.PACT Admiral: First FDA-Approved DCB for ISR
Sep 14 / Zacks.com - Paid Partner Content
NuVasive Grows in Pediatric Spine with FDA 510(k) for MAGEC
Sep 20 / Zacks.com - Paid Partner Content
Varian's (VAR) RapidPlan Gets Positive Feedback at AAPM
Sep 13 / Zacks.com - Paid Partner Content
Walgreens Partners EnvisionRx on 90-day Health Program
Sep 19 / Zacks.com - Paid Partner Content
Hologic: FDA OKs Expanded Emergency Use of Zika Virus Test
Sep 13 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Introduces New Vascular Dressing
Sep 19 / Zacks.com - Paid Partner Content
Masimo (MASI) Presents Encouraging SpHb Study Data
Sep 12 / Zacks.com - Paid Partner Content
Baxter (BAX) Now a Strong Buy on Solid Strategic Initiatives
Sep 19 / Zacks.com - Paid Partner Content
Myriad Genetics' TruCulture Study Results Favorable
Sep 12 / Zacks.com - Paid Partner Content
Glaukos Hits a 52-Week High on Positive Estimate Revisions
Sep 16 / Zacks.com - Paid Partner Content
Walgreens (WBA) to Divest More Stores to Close Rite Aid Deal
Sep 12 / Zacks.com - Paid Partner Content
Cepheid Announces Expansion of Molecular C. Difficile Product
Sep 16 / Zacks.com - Paid Partner Content
Cardiovascular Systems (CSII): Portfolio Robust, Woes Stay
Sep 12 / Zacks.com - Paid Partner Content
Zimmer Biomet Buys Clinical Graphics, Boosts Hip Business
Sep 16 / Zacks.com - Paid Partner Content